Výsledky vyhledávání

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas

Autor: Florian Lordick, Thomas Bruckner, L Sicic, Thomas Schmidt, T Parakonthun, M.W. Büchler, K. Becker, Rupert Langer, Katja Ott, J-R Siewert, Wilko Weichert, Susanne Blank

Publikováno v: British Journal of Cancer
Schmidt, T; Sicic, L; Blank, S; Becker, K; Weichert, W; Bruckner, T; Parakonthun, T; Langer, Rupert; Büchler, M W; Siewert, J-R; Lordick, F; Ott, K (2014). Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas. British journal of cancer, 110(7), pp. 1712-1720. Nature Publishing Group 10.1038/bjc.2014.94

BACKGROUND Recently, histopathological tumour regression, prevalence of signet ring cells, and localisation were reported as prognostic factors in neoadjuvantly treated oesophagogastric (junctional and gastric) cancer. This exploratory retrospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b303e2dc738714e7cc1a17ffe6be6dfd
https://doi.org/10.1038/bjc.2014.94

Zobrazit plný text záznamu

A reliable risk score for stage IV esophagogastric cancer

Autor: Henning Schulze-Bergkamen, P. Compani, Martin Dobritz, M.W. Büchler, Lars Grenacher, Maria Burian, Dirk Jäger, Katja Ott, Leila Sisic, Susanne Blank, Hendrik Bläker, Florian Lordick, Rupert Langer, J. R. Siewert, Wilfried Roth, Anja Schaible, Annika Stange, Karen Becker

Publikováno v: European Journal of Surgical Oncology (EJSO). 39:823-830

Background The role of surgery for patients with metastatic esophagogastric adenocarcinoma (EGC) is not defined. The purpose of this study was to define selection criteria for patients who may benefit from resection following systemic chemotherapy. M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f31e7d950009113a544b48e2d0fe8a92
https://doi.org/10.1016/j.ejso.2013.01.005

Zobrazit plný text záznamu

Surgical Treatment of Carcinomas Involving the Esophagogastric Junction

Autor: B.H.A. von Rahden, H. J. Stein, J. R. Siewert

Publikováno v: Gastrointestinal Oncology ISBN: 9780429074844

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c34668b148c22d47f30cf2785d89dc6
https://doi.org/10.3109/9781420021011-8

Zobrazit plný text záznamu

Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Autor: Hans-Jürgen Wester, Christian Peschel, Dirk Wilhelm, Ken Herrmann, Bernd J. Krause, Matthias P. Ebert, Hinrich Wieder, Katja Ott, Markus Schwaiger, Andreas K. Buck, J. R. Siewert, Florian Lordick, Tibor Schuster, Christian Meyer zum Büschenfelde, Rupert Langer, Karen Becker

Publikováno v: Annals of Surgical Oncology. 18:3316-3323

Metabolic imaging of gastric cancer is limited due to the 30% of primary tumors that are not 18F-fluorodeoxyglucose (FDG) avid. In contrast, the proliferation marker 18F-fluorothymidine (FLT) has been shown to visualize also non-FDG-avid gastric tumo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155500e2858a123fd0c71b64926afd7c
https://doi.org/10.1245/s10434-011-1743-y

Zobrazit plný text záznamu

Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas

Autor: Florian Lordick, Marcus Feith, Rupert Langer, J. R. Siewert, Karen Becker, Katja Ott

Publikováno v: Modern Pathology. 22:1555-1563

We evaluated histomorphological findings in 92 surgical resection specimens of locally advanced esophageal adenocarcinomas after neoadjuvant cisplatin-based chemotherapy. Tumor response to neoadjuvant chemotherapy was determined using a system encomp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cde0cba6a16f502338519421f13f317b
https://doi.org/10.1038/modpathol.2009.123

Zobrazit plný text záznamu

Neoadjuvante Therapie im oberen Gastrointestinaltrakt

Autor: H. J. Stein, J. R. Siewert, Marcus Feith

Publikováno v: Der Chirurg. 80:1019-1022

While primary surgical resection with systematic lymphadenectomy remains the treatment of choice for locoregional Barrett’s cancer, neoadjuvant chemotherapy is an increasingly accepted treatment modality for patients with locally advanced tumors an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa7b6797250285aed8b5d683627d8205
https://doi.org/10.1007/s00104-009-1734-8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání